Ras is active throughout the cell cycle, but is able to induce cyclin D1 only during G2 phase - PubMed (original) (raw)
Affiliations
- PMID: 12429909
Ras is active throughout the cell cycle, but is able to induce cyclin D1 only during G2 phase
Gaurisankar Sa et al. Cell Cycle. 2002 Jan.
Abstract
The control of cell cycle progression has been studied in asynchronous cultures using image analysis and time lapse techniques. This approach allows determination of the cycle phase and signaling properties of individual cells, and avoids the need for synchronization. In past studies this approach demonstrated that continuous cell cycle progression requires the induction of cyclin D1 levels by Ras, and that this induction takes place during G2 phase. These studies were designed to understand how Ras could induce cyclin D1 levels only during G2 phase. First, in studies with a Ras-specific promoter and cellular migration we find that endogenous Ras is active in all cell cycle phases of actively cycling NIH3T3 cells. This suggests that cyclin D1 induction during G2 phase is not the result of Ras activation specifically during this cell cycle period. To confirm this suggestion oncogenic Ras, which is expected to be active in all cell cycle phases, was microinjected into asynchronous cells. The injected protein induced cyclin D1 levels rapidly, but only in G2 phase cells. We conclude that in the continuously cycling cell the targets of Ras activity are controlled by cell cycle phase, and that this phenomenon is vital to cell cycle progression.
Comment in
- D1 in G2.
Sherr CJ. Sherr CJ. Cell Cycle. 2002 Jan;1(1):36-8. Cell Cycle. 2002. PMID: 12429906 Review. No abstract available.
Similar articles
- Cyclin D1 production in cycling cells depends on ras in a cell-cycle-specific manner.
Hitomi M, Stacey DW. Hitomi M, et al. Curr Biol. 1999 Oct 7;9(19):1075-84. doi: 10.1016/s0960-9822(99)80476-x. Curr Biol. 1999. PMID: 10531005 - Cellular ras and cyclin D1 are required during different cell cycle periods in cycling NIH 3T3 cells.
Hitomi M, Stacey DW. Hitomi M, et al. Mol Cell Biol. 1999 Jul;19(7):4623-32. doi: 10.1128/MCB.19.7.4623. Mol Cell Biol. 1999. PMID: 10373511 Free PMC article. - Ras-dependent cell cycle commitment during G2 phase.
Hitomi M, Stacey DW. Hitomi M, et al. FEBS Lett. 2001 Feb 16;490(3):123-31. doi: 10.1016/s0014-5793(01)02115-9. FEBS Lett. 2001. PMID: 11223027 Review. - Cyclin D1 serves as a cell cycle regulatory switch in actively proliferating cells.
Stacey DW. Stacey DW. Curr Opin Cell Biol. 2003 Apr;15(2):158-63. doi: 10.1016/s0955-0674(03)00008-5. Curr Opin Cell Biol. 2003. PMID: 12648671 Review. - Destabilization of cyclin D1 message plays a critical role in cell cycle exit upon mitogen withdrawal.
Guo Y, Harwalkar J, Stacey DW, Hitomi M. Guo Y, et al. Oncogene. 2005 Feb 3;24(6):1032-42. doi: 10.1038/sj.onc.1208299. Oncogene. 2005. PMID: 15592507
Cited by
- Ras signals principally via Erk in G1 but cooperates with PI3K/Akt for Cyclin D induction and S-phase entry.
Vasjari L, Bresan S, Biskup C, Pai G, Rubio I. Vasjari L, et al. Cell Cycle. 2019 Jan;18(2):204-225. doi: 10.1080/15384101.2018.1560205. Epub 2019 Jan 2. Cell Cycle. 2019. PMID: 30560710 Free PMC article. - Mutant K-Ras in Pancreatic Cancer: An Insight on the Role of Wild-Type N-Ras and K-Ras-Dependent Cell Cycle Regulation.
Ferguson R, Aughton K, Evans A, Shaw V, Armstrong J, Ware A, Bennett L, Costello E, Greenhalf W. Ferguson R, et al. Curr Issues Mol Biol. 2023 Mar 17;45(3):2505-2520. doi: 10.3390/cimb45030164. Curr Issues Mol Biol. 2023. PMID: 36975534 Free PMC article. - Regulation of Cell Cycle Progression by Growth Factor-Induced Cell Signaling.
Wang Z. Wang Z. Cells. 2021 Nov 26;10(12):3327. doi: 10.3390/cells10123327. Cells. 2021. PMID: 34943835 Free PMC article. Review. - Anti cancer effects of curcumin: cycle of life and death.
Sa G, Das T. Sa G, et al. Cell Div. 2008 Oct 3;3:14. doi: 10.1186/1747-1028-3-14. Cell Div. 2008. PMID: 18834508 Free PMC article. - Stochastic modeling suggests that noise reduces differentiation efficiency by inducing a heterogeneous drug response in glioma differentiation therapy.
Sun X, Zhang J, Zhao Q, Chen X, Zhu W, Yan G, Zhou T. Sun X, et al. BMC Syst Biol. 2016 Aug 11;10(1):73. doi: 10.1186/s12918-016-0316-x. BMC Syst Biol. 2016. PMID: 27515956 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Research Materials
Miscellaneous